JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BOURNE, H. R.
Right arrow Articles by MELMON, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BOURNE, H. R.
Right arrow Articles by MELMON, K. L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 178, Issue 1, 1-7, 1971
Copyright © 1971 by American Society for Pharmacology and Experimental Therapeutics


ADENYL CYCLASE IN HUMAN LEUKOCYTES: EVIDENCE FOR ACTIVATION BY SEPARATE BETA ADRENERGIC AND PROSTAGLANDIN RECEPTORS

HENRY R. BOURNE 1 and KENNETH L. MELMON 1

1 Division of Clinical Pharmacology, Departments of Medicine and Pharmacology and Cardiovascular Research institute, School of Medicine, University of California Medical Center, San Francisco, California

The effects of drugs on adenyl cyclase activity in isolated human leukocytes were examined in two ways: 1) conversion of radioactive adenosine triphosphate to cyclic adenosine monophosphate (AMP) by broken cell preparations; and 2) accumulation of radioactive cyclic AMP within intact leukoytes after preincubation with radioactive adenine. Synthesis of cyclic AMP was increased by prostaglandin-E1(PGE1) and selected catecholamines, but not by glucagon or adrenocorticotropin. Responses to catecholamines were characteristic of a beta adrenergic receptor, both in order of potency or agonists [isoproterenol = epinephrine > norepinephrine > phenylephrine (= 0)] and in being competitively inhibited by beta adrenergic antagonists (propranolol and MJ-1999) but not by alpha antagonists (phentolamine and Dibenamine). The effect of PGE1 was not blocked by propranolol. PGE1 and isoproterenol at maximally effective doses produced no additive effect on cyclic AMP synthesis, suggesting that both drugs stimulate different receptors, but activate the same adenyl cyclase enzyme. The maximum effect of isoproterenol is only about 15% of that produced by PGE1; the possibility that isoproterenol stimulates adenyl cyclase in a fraction of the leukocytes (or specific types of leukocytes) has not been ruled out.

Submitted on January 25, 1971
Accepted on April 2, 1971




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
A. P. Kohm and V. M. Sanders
Norepinephrine and beta 2-Adrenergic Receptor Stimulation Regulate CD4+ T and B Lymphocyte Function in Vitro and in Vivo
Pharmacol. Rev., December 1, 2001; 53(4): 487 - 525.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
O. Brodde, R Kretsch, K Ikezono, H. Zerkowski, and J. Reidemeister
Human beta-adrenoceptors: relation of myocardial and lymphocyte beta-adrenoceptor density
Science, March 28, 1986; 231(4745): 1584 - 1585.
[Abstract] [PDF]


Home page
ScienceHome page
K. L. Melmon, H. R. Bourne, J. Weinstein, and M. Sela
Receptors for Histamine Can Be Detected on the Surface of Selected Leukocytes
Science, August 25, 1972; 177(4050): 707 - 709.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics.